Mason Street Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28,046
| Closed | -$555K | – | 817 |
|
|
2020
Q4 | $555K | Buy |
28,046
+17
| +0.1% | +$336 | 0.01% | 1134 |
|
|
2020
Q3 | $365K | Buy |
28,029
+39
| +0.1% | +$508 | 0.01% | 1187 |
|
|
2020
Q2 | $317K | Buy |
27,990
+2,080
| +8% | +$23.6K | 0.01% | 1219 |
|
|
2020
Q1 | $371K | Hold |
25,910
| – | – | 0.01% | 1094 |
|
|
2019
Q4 | $706K | Buy |
25,910
+828
| +3% | +$22.6K | 0.01% | 1014 |
|
|
2019
Q3 | $718K | Buy |
25,082
+590
| +2% | +$16.9K | 0.01% | 978 |
|
|
2019
Q2 | $680K | Buy |
24,492
+960
| +4% | +$26.7K | 0.01% | 999 |
|
|
2019
Q1 | $781K | Buy |
23,532
+315
| +1% | +$10.5K | 0.02% | 980 |
|
|
2018
Q4 | $675K | Buy |
23,217
+2,203
| +10% | +$64K | 0.02% | 946 |
|
|
2018
Q3 | $967K | Buy |
21,014
+827
| +4% | +$38.1K | 0.02% | 887 |
|
|
2018
Q2 | $754K | Buy |
20,187
+810
| +4% | +$30.3K | 0.02% | 955 |
|
|
2018
Q1 | $573K | Buy |
19,377
+1,368
| +8% | +$40.5K | 0.01% | 996 |
|
|
2017
Q4 | $619K | Buy |
18,009
+676
| +4% | +$23.2K | 0.01% | 964 |
|
|
2017
Q3 | $627K | Buy |
17,333
+535
| +3% | +$19.4K | 0.01% | 953 |
|
|
2017
Q2 | $434K | Buy |
16,798
+876
| +6% | +$22.6K | 0.01% | 1035 |
|
|
2017
Q1 | $306K | Buy |
+15,922
| New | +$306K | 0.01% | 1129 |
|
|
2015
Q1 | – | Sell |
-7,090
| Closed | -$241K | – | 1656 |
|
|
2014
Q4 | $241K | Sell |
7,090
-340
| -5% | -$11.6K | ﹤0.01% | 1443 |
|
|
2014
Q3 | $287K | Hold |
7,430
| – | – | ﹤0.01% | 1412 |
|
|
2014
Q2 | $289K | Sell |
7,430
-1,120
| -13% | -$43.6K | ﹤0.01% | 1399 |
|
|
2014
Q1 | $292K | Sell |
8,550
-840
| -9% | -$28.7K | ﹤0.01% | 1373 |
|
|
2013
Q4 | $197K | Sell |
9,390
-240
| -2% | -$5.04K | ﹤0.01% | 1516 |
|
|
2013
Q3 | $226K | Sell |
9,630
-6,220
| -39% | -$146K | ﹤0.01% | 1272 |
|
|
2013
Q2 | $426K | Buy |
+15,850
| New | +$426K | ﹤0.01% | 1082 |
|